Ignite Creation Date:
2024-05-06 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 2:22 PM
Study NCT ID:
NCT05199051
Status:
RECRUITING
Last Update Posted:
2023-11-13
First Post:
2021-11-12
Brief Title:
A Phase 2 Study of Gemtuzumab Ozogamicin GO-Gilteritinib Combination in Adults With FLT3-ITD RelapseRefractory RR AML
Sponsor:
Centre Antoine Lacassagne
Organization:
Centre Antoine Lacassagne
Organization Data
Organization:
Centre Antoine Lacassagne
Class:
OTHER
Study ID:
202065
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Centre Antoine Lacassagne
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Acute Leukemia French Association | OTHER |